C
Carlos Mena-Hurtado
Researcher at Yale University
Publications - 144
Citations - 1142
Carlos Mena-Hurtado is an academic researcher from Yale University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 12, co-authored 76 publications receiving 597 citations. Previous affiliations of Carlos Mena-Hurtado include Harvard University.
Papers
More filters
Journal ArticleDOI
Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis).
Eric J. Dippel,Prakash Makam,Richard Kovach,Jon C. George,Raghotham R. Patlola,D. Christopher Metzger,Carlos Mena-Hurtado,Robert Beasley,Peter A. Soukas,Pedro J. Colon-Hernandez,Matthew A. Stark,Craig M. Walker,Excite Isr Investigators +12 more
TL;DR: The EXCITE ISR trial is the first large, prospective, randomized study to demonstrate superiority of ELA + PTA versus PTA alone for treating femoropopliteal ISR, with significantly fewer procedural complications.
Journal ArticleDOI
Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies.
Prakash Krishnan,Peter Faries,Khusrow Niazi,Ash Jain,Ravish Sachar,William Bachinsky,Joseph A. Cardenas,Martin Werner,Marianne Brodmann,Jihad A. Mustapha,Carlos Mena-Hurtado,Michael R. Jaff,Andrew Holden,Sean P. Lyden +13 more
TL;DR: The data demonstrate superior safety and effectiveness of the Stellarex DCB in comparison with PTA, and plasma levels of paclitaxel fall to low levels within 1 hour, as well as investigating the pharmacokinetic and clinical outcomes of a new DCB to treat femoropopliteal disease.
Journal ArticleDOI
Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia.
Alik Farber,Matthew T. Menard,Michael S. Conte,John A. Kaufman,Richard J. Powell,Niteesh K. Choudhry,Taye H. Hamza,Susan F. Assmann,Mark A. Creager,Mark J. Cziraky,Michael D. Dake,Michael R. Jaff,Diane Reid,Flora S. Siami,George Sopko,Christopher J. White,Maxwell Van Over,Michael Strong,Maria F. Villarreal,Michelle McKean,Ezana M. Azene,Amir F. Azarbal,Andrew Barleben,David K.W. Chew,Leonardo C. Clavijo,Yvan Douville,Laura K. Findeiss,Nitin Garg,Warren J. Gasper,Kristina A. Giles,Philip P. Goodney,Beau M. Hawkins,C. Herman,Jeffrey A. Kalish,Matthew C. Koopmann,Igor Laskowski,Carlos Mena-Hurtado,Raghu L. Motaganahalli,Vincent L. Rowe,Andres Schanzer,O. Schneider,Jeffrey J. Siracuse,Maarit Venermo,Kenneth Rosenfield +43 more
TL;DR: In this article , an international, randomized trial was conducted to investigate whether an initial strategy of endovascular therapy or surgical revascularization for chronic limb-threatening ischemia (CLTI) is superior for improving limb outcomes.
Journal ArticleDOI
Review of coronary subclavian steal syndrome
Bennett Cua,Natasha Mamdani,David Halpin,Sunny Jhamnani,Sasanka Jayasuriya,Carlos Mena-Hurtado +5 more
TL;DR: An algorithm for SAS screening to prevent coronary subclavian steal syndrome in internal mammary artery bypass recipients is provided and treatment options in the percutaneous era are reviewed.
Journal ArticleDOI
Principles of Intravascular Lithotripsy for Calcific Plaque Modification.
Dean J. Kereiakes,Renu Virmani,Jason Y. Hokama,Uday Illindala,Carlos Mena-Hurtado,Andrew Holden,Jonathan Hill,Sean P. Lyden,Ziad A. Ali +8 more
TL;DR: In this article, the authors summarize the physics, preclinical and clinical data on intravascular lithotripsy (IVL) use in the coronary and peripheral vasculature, and future directions of IVL in transcatheter cardiovascular therapies.